THE TREATMENT OF PARKINSONISM WITH UK 738: A CLINICAL TRIAL
Abstract
These results show that UK 738 has only a very slight effect on the symptoms of naturally occuring parkinsonism, and it is not as effective as benzhexol. When compared with a dummy in a double blind trial, benzhexol itself is not outstandingly effective.
These results are very different from those obtained by May and his colleagues (3, 4) and although their cases were of phenothiazine induced parkinsonism, it is more likely that the discrepancy is due to their lack of control in the trial than to any difference in aetiology.
Access content
To read the fulltext, please use one of the options below to sign in or purchase access.- Personal login
- Institutional Login
- Sign in via OpenAthens
- Register for access
-
Please login/register if you wish to pair your device and check access availability.
Not a subscriber?
PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.
Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).